Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Unlocking the Rosetta Stone enigma for nasopharyngeal carcinoma: genetics, viral infection, and epidemiological factors.

Lung ML.

Semin Cancer Biol. 2012 Apr;22(2):77-8. doi: 10.1016/j.semcancer.2012.01.006. Epub 2012 Jan 14. No abstract available.

PMID:
22266061
2.

Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches.

Lo KW, Chung GT, To KF.

Semin Cancer Biol. 2012 Apr;22(2):79-86. doi: 10.1016/j.semcancer.2011.12.011. Epub 2012 Jan 10. Review.

PMID:
22245473
3.
4.

Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility.

Guo XC, Scott K, Liu Y, Dean M, David V, Nelson GW, Johnson RC, Dilks HH, Lautenberger J, Kessing B, Martenson J, Guan L, Sun S, Deng H, Zheng Y, de The G, Liao J, Zeng Y, O'Brien SJ, Winkler CA.

Hum Genomics. 2006 Jun;2(6):365-75.

5.

[Epstein-Barr virus and nasopharyngeal carcinoma].

Friborg JT, Melbye M.

Ugeskr Laeger. 2002 Dec 9;164(50):5908-11. Danish. No abstract available.

PMID:
12553107
6.
7.

Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.

Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL, Xia JC, Wang HY, Feng QS, Ren ZF, Ernberg I, Hu LF, Zeng YX.

Anticancer Res. 2001 Jul-Aug;21(4B):3021-9.

PMID:
11712805
8.

Aetiology of nasopharyngeal carcinoma. A review.

Kumar S, Mahanta J.

Indian J Cancer. 1998 Jun;35(2):47-56. Review.

PMID:
9849024
9.

Is nasopharyngeal cancer really a "Cantonese cancer"?

Wee JT, Ha TC, Loong SL, Qian CN.

Chin J Cancer. 2010 May;29(5):517-26.

10.

[Nasopharyngeal carcinomas and Epstein-Barr virus: from epidemiology and detection to therapy].

Busson P, Ooka T, Corbex M.

Med Sci (Paris). 2004 Apr;20(4):453-7. Review. French.

11.

Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection.

Mutirangura A, Tanunyutthawongese C, Pornthanakasem W, Kerekhanjanarong V, Sriuranpong V, Yenrudi S, Supiyaphun P, Voravud N.

Br J Cancer. 1997;76(6):770-6.

12.

Genetic and epigenetic changes in nasopharyngeal carcinoma.

Lo KW, Huang DP.

Semin Cancer Biol. 2002 Dec;12(6):451-62. Review.

PMID:
12450731
13.

Concomitant EBV encoded RNA positive cutaneous nasal-type natural killer-cell lymphoma and EBV encoded RNA negative nasopharyngeal carcinoma.

Au WY, Law MF, Tung Y, Shek TW.

Leuk Lymphoma. 2009 Sep;50(9):1543-4. doi: 10.1080/10428190903104497. No abstract available.

PMID:
19603349
14.

[The biology of nasopharyngeal carcinoma in 2001: update and perspective].

Busson P, Ardila-Osorio H, Pioche-Durieu C, Vicat JM.

Cancer Radiother. 2001 Nov;5 Suppl 1:184s-188s. Review. French.

PMID:
11797280
15.

[In situ hybridization in undifferentiated nasopharynx carcinoma in Tunisia. Report of 3 cases].

Baizig Nehla M, Hamouda B, Asma K, Farhat BA, Abderahmen L, Omrane BH, Ahmed el M.

Tunis Med. 2001 Oct;79(10):544-7. French.

PMID:
11910697
16.

Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population.

Cao Y, Miao XP, Huang MY, Deng L, Hu LF, Ernberg I, Zeng YX, Lin DX, Shao JY.

BMC Cancer. 2006 Jun 26;6:167.

17.

Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland.

Friborg J, Jarrett RF, Liu MY, Falk KI, Koch A, Olsen OR, Duncan P, Wohlfarht J, Chen JY, Melbye M.

J Med Virol. 2007 Dec;79(12):1877-81.

PMID:
17935169
18.

The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma.

Li DJ, Bei JX, Mai SJ, Xu JF, Chen LZ, Zhang RH, Yu XJ, Hong MH, Zeng YX, Kang T.

J Med Virol. 2009 Jul;81(7):1253-60. doi: 10.1002/jmv.21503.

PMID:
19475622
19.

Lymphoepithelioma-like carcinoma and its relationship to Epstein-Barr virus.

Weiss LM, Gaffey MJ, Shibata D.

Am J Clin Pathol. 1991 Aug;96(2):156-8. No abstract available.

PMID:
1650531
20.

Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects.

Fachiroh J, Schouten T, Hariwiyanto B, Paramita DK, Harijadi A, Haryana SM, Ng MH, Middeldorp JM.

J Infect Dis. 2004 Jul 1;190(1):53-62. Epub 2004 May 26.

PMID:
15195243

Supplemental Content

Support Center